多发性-话题@MedSci

#多发性#

905篇内容 | 2949人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890277, encodeId=d86d18902e778, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology-自体造血干细胞移植，治疗多发性硬化，疗效和风险共存, objectType=article, longId=214363, objectId=32b921436368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b921436368, replyNumber=0, likeNumber=81, createdTime=2021-09-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b921436368, moduleTitle=Neurology-自体造血干细胞移植，治疗多发性硬化，疗效和风险共存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b921436368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890311, encodeId=e40d189031168, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：多发性硬化患者的疾病修饰疗法与新冠肺炎严重程度的关系, objectType=article, longId=218833, objectId=07a92188331d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07a92188331d, replyNumber=0, likeNumber=87, createdTime=2021-12-29, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07a92188331d, moduleTitle=Neurology：多发性硬化患者的疾病修饰疗法与新冠肺炎严重程度的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07a92188331d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890326, encodeId=3138189032641, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关, objectType=article, longId=220763, objectId=d703220e63d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d703220e63d2, replyNumber=0, likeNumber=0, createdTime=2022-05-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d703220e63d2, moduleTitle=Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d703220e63d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890258, encodeId=d7d6189025868, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：多发性硬化症：当出现疲劳和瞌睡的患者，更容易出现中枢性嗜睡, objectType=article, longId=212138, objectId=7312212138e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7312212138e4, replyNumber=0, likeNumber=69, createdTime=2021-06-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7312212138e4, moduleTitle=Neurology：多发性硬化症：当出现疲劳和瞌睡的患者，更容易出现中枢性嗜睡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7312212138e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890217, encodeId=059c189021e88, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=欧洲接受CAR-T疗法Ciltacabtagene Autoleucel（Cilta-cel）的加速评估，以治疗多发性骨髓瘤, objectType=article, longId=206689, objectId=8a6220668996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a6220668996, replyNumber=0, likeNumber=72, createdTime=2021-07-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a6220668996, moduleTitle=欧洲接受CAR-T疗法Ciltacabtagene Autoleucel（Cilta-cel）的加速评估，以治疗多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a6220668996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890271, encodeId=7e6018902e175, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Ann Neurol-多发性硬化症，肠道菌群“作用”非同一般, objectType=article, longId=213864, objectId=d24f2138647c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24f2138647c, replyNumber=0, likeNumber=65, createdTime=2022-03-29, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24f2138647c, moduleTitle=Ann Neurol-多发性硬化症，肠道菌群“作用”非同一般, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24f2138647c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890305, encodeId=a1e41890305f9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=一文了解多发性内分泌瘤-1（MEN1）的临床表现及诊断, objectType=article, longId=217931, objectId=e27b21e931dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27b21e931dd, replyNumber=0, likeNumber=85, createdTime=2021-10-28, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27b21e931dd, moduleTitle=一文了解多发性内分泌瘤-1（MEN1）的临床表现及诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27b21e931dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890264, encodeId=60381890264dc, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology:复发性发病的多发性硬化患者，年龄比疾病持续时间对死亡率影响更大, objectType=article, longId=212798, objectId=cff8212e98d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cff8212e98d2, replyNumber=0, likeNumber=107, createdTime=2021-07-07, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cff8212e98d2, moduleTitle=Neurology:复发性发病的多发性硬化患者，年龄比疾病持续时间对死亡率影响更大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cff8212e98d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890336, encodeId=d321189033679, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：青少年胖一点，多发性硬化风险就高一点！, objectType=article, longId=265028, objectId=52292650287d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52292650287d, replyNumber=0, likeNumber=79, createdTime=2022-02-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52292650287d, moduleTitle=Neurology：青少年胖一点，多发性硬化风险就高一点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52292650287d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890302, encodeId=dee618903022a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：血清神经丝光与那他珠单抗治疗的复发缓解型多发性硬化患者病情进展的关系, objectType=article, longId=217574, objectId=9cde21e5742c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cde21e5742c, replyNumber=0, likeNumber=75, createdTime=2022-04-18, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cde21e5742c, moduleTitle=Neurology：血清神经丝光与那他珠单抗治疗的复发缓解型多发性硬化患者病情进展的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cde21e5742c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890200, encodeId=f6b91890200a4, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：感染新冠肺炎的多发性骨髓瘤患者的预后及相关危险因素, objectType=article, longId=205048, objectId=cddb2050481b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cddb2050481b, replyNumber=0, likeNumber=106, createdTime=2021-07-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cddb2050481b, moduleTitle=Blood：感染新冠肺炎的多发性骨髓瘤患者的预后及相关危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cddb2050481b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890283, encodeId=85dd1890283b1, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP：抗CD20单抗疗法降低多发性硬化症或视神经脊髓炎患者对SARS-CoV-2的体液免疫应答, objectType=article, longId=215532, objectId=d6f5215532da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6f5215532da, replyNumber=0, likeNumber=133, createdTime=2021-10-10, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6f5215532da, moduleTitle=JNNP：抗CD20单抗疗法降低多发性硬化症或视神经脊髓炎患者对SARS-CoV-2的体液免疫应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6f5215532da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890206, encodeId=718b189020696, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle= JNNP:多发性硬化注射治疗转向口服治疗的的效果：一项全国性队列研究, objectType=article, longId=205926, objectId=483420592603, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=483420592603, replyNumber=0, likeNumber=98, createdTime=2021-02-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=483420592603, moduleTitle= JNNP:多发性硬化注射治疗转向口服治疗的的效果：一项全国性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=483420592603)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890270, encodeId=558618902e003, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Blood：口服伊沙佐米-来那度胺-地塞米松治疗不能移植的新确诊多发性骨髓瘤, objectType=article, longId=213768, objectId=981b213e68a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=981b213e68a9, replyNumber=0, likeNumber=96, createdTime=2021-12-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=981b213e68a9, moduleTitle=Blood：口服伊沙佐米-来那度胺-地塞米松治疗不能移植的新确诊多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=981b213e68a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890219, encodeId=680b1890219fd, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Nat Commun：多发性骨髓瘤患者中BCMA的双等位基因缺失引起CAR-T疗法耐药性的产生, objectType=article, longId=207031, objectId=34d520e0312e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34d520e0312e, replyNumber=0, likeNumber=59, createdTime=2021-02-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34d520e0312e, moduleTitle=Nat Commun：多发性骨髓瘤患者中BCMA的双等位基因缺失引起CAR-T疗法耐药性的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34d520e0312e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890296, encodeId=13d018902965d, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet Oncol：达雷妥尤单抗维持治疗可显著降低多发性骨髓瘤患者的疾病进展及死亡风险, objectType=article, longId=217213, objectId=d65521e213ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d65521e213ea, replyNumber=0, likeNumber=69, createdTime=2022-05-23, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d65521e213ea, moduleTitle=Lancet Oncol：达雷妥尤单抗维持治疗可显著降低多发性骨髓瘤患者的疾病进展及死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d65521e213ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890234, encodeId=85db18902348a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=BMS的CAR-T细胞疗法治疗多发性骨髓瘤，已获得FDA批准, objectType=article, longId=209107, objectId=d5a420910e55, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5a420910e55, replyNumber=0, likeNumber=62, createdTime=2021-06-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5a420910e55, moduleTitle=BMS的CAR-T细胞疗法治疗多发性骨髓瘤，已获得FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5a420910e55)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890195, encodeId=a83818901950f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Oncopeptides发表多发性骨髓瘤Ⅱ期ANCHOR联合研究的新数据, objectType=article, longId=204399, objectId=60b820439979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60b820439979, replyNumber=0, likeNumber=73, createdTime=2021-08-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60b820439979, moduleTitle=Oncopeptides发表多发性骨髓瘤Ⅱ期ANCHOR联合研究的新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60b820439979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890309, encodeId=6a4018903092c, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet oncol：3期| 达雷妥尤单抗+来那度胺一线治疗不适移植的多发性骨髓瘤的疗效可期！, objectType=article, longId=218592, objectId=454b218592dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=454b218592dd, replyNumber=0, likeNumber=100, createdTime=2022-08-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=454b218592dd, moduleTitle=Lancet oncol：3期| 达雷妥尤单抗+来那度胺一线治疗不适移植的多发性骨髓瘤的疗效可期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=454b218592dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890218, encodeId=14af1890218e0, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Br J Cancer：酯酶基因表达水平在多发性骨髓瘤中的预后意义, objectType=article, longId=206796, objectId=97c0206e965e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97c0206e965e, replyNumber=0, likeNumber=83, createdTime=2021-05-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97c0206e965e, moduleTitle=Br J Cancer：酯酶基因表达水平在多发性骨髓瘤中的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97c0206e965e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology-自体造血干细胞移植，治疗多发性硬化，疗效和风险共存

2021-09-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：多发性硬化患者的疾病修饰疗法与新冠肺炎严重程度的关系

2021-12-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关

2022-05-20

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：多发性硬化症：当出现疲劳和瞌睡的患者，更容易出现中枢性嗜睡

2021-06-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

欧洲接受CAR-T疗法Ciltacabtagene Autoleucel（Cilta-cel）的加速评估，以治疗多发性骨髓瘤

2021-07-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Ann Neurol-多发性硬化症，肠道菌群“作用”非同一般

2022-03-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

一文了解多发性内分泌瘤-1（MEN1）的临床表现及诊断

2021-10-28

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology:复发性发病的多发性硬化患者，年龄比疾病持续时间对死亡率影响更大

2021-07-07

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：青少年胖一点，多发性硬化风险就高一点！

2022-02-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：血清神经丝光与那他珠单抗治疗的复发缓解型多发性硬化患者病情进展的关系

2022-04-18

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：感染新冠肺炎的多发性骨髓瘤患者的预后及相关危险因素

2021-07-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP：抗CD20单抗疗法降低多发性硬化症或视神经脊髓炎患者对SARS-CoV-2的体液免疫应答

2021-10-10

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:多发性硬化注射治疗转向口服治疗的的效果：一项全国性队列研究

2021-02-21

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Blood：口服伊沙佐米-来那度胺-地塞米松治疗不能移植的新确诊多发性骨髓瘤

2021-12-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Nat Commun：多发性骨髓瘤患者中BCMA的双等位基因缺失引起CAR-T疗法耐药性的产生

2021-02-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet Oncol：达雷妥尤单抗维持治疗可显著降低多发性骨髓瘤患者的疾病进展及死亡风险

2022-05-23

jml2009 (审核中...)

前往app查看评论内容

#多发性#

BMS的CAR-T细胞疗法治疗多发性骨髓瘤，已获得FDA批准

2021-06-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Oncopeptides发表多发性骨髓瘤Ⅱ期ANCHOR联合研究的新数据

2021-08-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet oncol：3期| 达雷妥尤单抗+来那度胺一线治疗不适移植的多发性骨髓瘤的疗效可期！

2022-08-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Br J Cancer：酯酶基因表达水平在多发性骨髓瘤中的预后意义

2021-05-27

科室
- - 订阅+
  - 更多科室
工具
服务